IRIS
SCIONTI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.045
AS - Asia 778
EU - Europa 734
SA - Sud America 130
AF - Africa 40
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 987
IT - Italia 347
SG - Singapore 301
CN - Cina 153
IN - India 117
BR - Brasile 104
DE - Germania 96
GB - Regno Unito 87
FI - Finlandia 51
CA - Canada 37
SE - Svezia 34
HK - Hong Kong 33
VN - Vietnam 33
NL - Olanda 27
PK - Pakistan 24
JO - Giordania 21
ID - Indonesia 20
ES - Italia 16
ZA - Sudafrica 15
MX - Messico 14
RU - Federazione Russa 14
FR - Francia 12
BD - Bangladesh 11
CZ - Repubblica Ceca 10
EG - Egitto 10
SA - Arabia Saudita 9
LT - Lituania 8
TR - Turchia 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
PT - Portogallo 7
AU - Australia 6
IQ - Iraq 6
NG - Nigeria 6
PE - Perù 6
EC - Ecuador 5
ET - Etiopia 5
IE - Irlanda 5
IR - Iran 5
LB - Libano 5
AR - Argentina 4
CY - Cipro 4
MY - Malesia 4
RO - Romania 4
BG - Bulgaria 3
JP - Giappone 3
PH - Filippine 3
PS - Palestinian Territory 3
UA - Ucraina 3
AL - Albania 2
AT - Austria 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 2.737
Salva come PNG Salva come JPEG
Città #
Singapore 190
Chandler 161
Dallas 87
Munich 72
Ashburn 65
Santa Clara 65
Bengaluru 57
Hefei 56
Chicago 55
London 48
Milan 38
Turku 35
Lawrence 34
Princeton 34
Beijing 31
Catanzaro 27
Hong Kong 23
Los Angeles 20
Boardman 19
Ottawa 19
Helsinki 16
Wilmington 15
Amman 13
Ho Chi Minh City 13
Carbonia 12
New York 12
San Nicola Manfredi 12
Rome 11
San Francisco 10
Spezzano della Sila 10
Brooklyn 9
Delhi 8
Irbid 8
Madrid 8
Naples 8
Olomouc 8
Palermo 8
São Paulo 8
Chennai 7
Cosenza 7
Kaunas 7
The Dalles 7
Atlanta 6
Des Moines 6
Ercolano 6
Frankfurt am Main 6
Redmond 6
Afragola 5
Aversa 5
Cardiff 5
Hanoi 5
Hyderabad 5
Johannesburg 5
Lucknow 5
Meppel 5
Pune 5
Riyadh 5
Sacramento 5
Santo Stefano di Rogliano 5
Seattle 5
Stockholm 5
Addis Ababa 4
Ahmedabad 4
Brescia 4
Cape Town 4
Catania 4
Council Bluffs 4
Dhaka 4
Islamabad 4
Jeddah 4
Kuala Lumpur 4
Lahore 4
Manchester 4
Montreal 4
Nicosia 4
Toronto 4
Tubarão 4
Acquaviva delle Fonti 3
Ajman 3
Amsterdam 3
Andover 3
Ankara 3
Banyumas 3
Berlin 3
Bologna 3
Bristol 3
Campo Grande 3
Castrovillari 3
Charlotte 3
Chía 3
Da Nang 3
Decollatura 3
Dubai 3
Faisalabad 3
Florianópolis 3
Guangzhou 3
Guarulhos 3
Hanover 3
Istanbul 3
Lima 3
Totale 1.586
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 402
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 112
miR-22 suppresses DNA ligase III addiction in multiple myeloma 92
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 91
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 75
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis 66
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 65
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 64
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 62
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 60
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 56
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 54
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 54
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 53
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 50
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 50
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 49
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 48
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 47
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 47
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 47
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 46
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 45
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 44
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 44
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 44
The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders 43
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 42
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 41
GENETIC SUSCEPTIBILITY TO GASTROINTESTINAL SYMPTOMS IN FABRY DISEASE 41
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 41
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 41
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 40
Mmrf-commpass data integration and analysis for identifying prognostic markers 40
Integration of DNA Microarray with Clinical and Genomic Data 40
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 39
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 38
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine 38
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 36
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 35
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 35
The Effect of Physical Activity/Exercise on miRNA Expression and Function in Non-Communicable Diseases-A Systematic Review 33
Ethical Perspectives on Pharmacogenomic Profiling 32
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 32
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 31
null 31
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma 28
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 27
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. (IF 5.168) 27
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 26
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 25
Advances in Alport syndrome diagnosis using next-generation sequencing 23
The potential role of miRNAs in multiple myeloma therapy 21
Functional Role of Linc-RNAs in Multiple Myeloma: Linc-MIR17HG Affects Fatty Acid Biosynthesis Via transcriptional Regulation of ACC1 with Potential Therapeutic Implications 20
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 17
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 14
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome 14
Raman spectroscopic characterization of liver steatosis and fibrosis in a 2D and 3D in vitro thyroxine-treated hypothyroid cellular model 7
Totale 2.865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.678
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 5 6 6 7 9 12 1 0
2021/2022156 1 0 0 32 8 0 8 29 36 19 17 6
2022/2023453 75 31 22 19 59 40 7 33 60 33 49 25
2023/2024511 91 40 46 35 48 74 28 41 10 17 31 50
2024/2025976 92 33 33 50 62 126 73 60 56 23 156 212
2025/2026647 130 173 147 191 6 0 0 0 0 0 0 0
Totale 2.865